Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/656046


The Europe Biotechnology Sectors : A Company and Industry Analysis (October 2007)


Description: This report updates the previous European biotechnology report, focusing on the markets in France, Germany, the Netherlands, Sweden, Switzerland, and the United Kingdom
Current Environment - Key Points
- The past six months saw the maturing of European biotechs. A number of successful initial public offerings over the past six months suggested that biotechs are set to deliver products with potential for big returns. - US biotech indices, the NASDAQ Biotech index (+6.6%) and the AMEX Biotech index (+10.2%), outperformed the European WestLB Biotech index (+0.6%) between January 1 and May 15 this year. Leading biotechs recorded higher gains as the market capitalization of leading biotechs in Europe rose 5% between March 7 and September 21, according to a Mergent analysis. - Deal-making remained active in the past six months as drug giants snapped up promising therapies from smaller developers in order to beef up their pipelines. Qiagen (NASDAQ: QGEN) acquired US-based Digene for US$1.6 billion
- Seven European biotechs went public, raising a total of US$442 million, according to a Mergent analysis. The largest IPO was completed by Switzerland-s Addex Pharmaceuticals (SWX: ADXN) which raised CHF137 million (US$115.4 million) in May.
Industry Profile - Key Points
- A public-private partnership aimed at boosting new drug development in Europe, the Innovative Medicines Initiative (IMI), is on track to come into effect this year with total funding amounting to -2 billion (US$2.8 billion)
- Europe has taken a big step to aid SMEs, which presents another funding opportunity for biotech start-ups. The Eurostars Programme, under the EUREKA funding scheme, will be launched in October
- European Union (EU) ministers decided to forge ahead with a new EU system for centralized review of all gene, cell and tissue-based therapies in the EU by voting in favor of proposed regulations on advanced therapies. Europe will soon have a harmonized legal framework in place for these innovative products that could start as early as January 2008. - European biopharmaceutical companies now have to face extended preclinical testing requirements if their drug candidates fall into the newly created category of -high risk products-
Market Trends & Outlook - Key Points - Due to rising demand for biofuels, new processing routes for crude oil are being found. Over the next five years, the BIOCOUP project, supported through the Sixth Framework Programme for Research and Technical Development, will devise a series of steps that will allow biomass feedstock to be co-fed into a conventional oil refinery
- European researchers are developing techniques where artificially introduced RNAs are capable of canceling out disease causing proteins. The -11.8 million (US$16.4 million) Integrated Project will further investigate these methods with the aim of eventually making life threatening diseases a thing of the past. - Young researchers are looking to Europe to establish careers in stem cell research, due to initiatives such as the Marie-Curie mobility grants and the flagship project EuroStemCell, funded under the EU-s framework program


Contents: Current Environment
- Sector Overview
- Sector Performance
- Leading Companies
- Mergers, Acquisitions and
Alliances
- Initial Public Offerings
Industry Profile
- Sector Size and Value
- Industry Focus Areas
- Sector Investment
- Government Investment
- Policy and Regulatory
Environment
Market Trends and Outlook
- Biofuels to be Processed by Oil
Refineries
- Large EU-funded RNA
Silencing Project Gets
Underway
- Young Researchers Look to
Europe for Stem Cell Careers
- Market Outlook
Country Profiles
- France
- Germany
- The Netherlands
- Sweden
- Switzerland
- United Kingdom
Currency Conversion Table
The Scope of This Report
Key References
Comparative Data
Reports Coverage




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/656046

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 23:32:00
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The Europe Biotechnology Sectors : A Company and Industry Analysis (October 2007)
Web Address:
http://www.researchandmarkets.com/reports/656046
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €200.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 23:32:00

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)